Researchers at Stanford Medicine have identified a promising strategy to reverse cartilage loss linked to aging and arthritis. Their study shows that an injection blocking the protein 15-PGDH restores naturally deteriorating knee cartilage in aged mice. Moreover, the treatment prevents arthritis after knee injuries similar to ACL tears commonly experienced by athletes and recreational exercisers.
Importantly, an oral version of this therapy is already undergoing clinical trials for age-related muscle weakness, raising hopes that cartilage regeneration may soon become clinically feasible.
Human Cartilage Also Responds to Treatment
The researchers extended their work to human tissue obtained during knee replacement surgeries. These samples included both the extracellular matrix — the structural scaffolding of joints — and cartilage-producing chondrocytes. After treatment with the 15-PGDH inhibitor, the tissues began forming new, functional articular cartilage.
Therefore, the findings suggest that clinicians may eventually regenerate cartilage lost to aging or osteoarthritis using either a local injection or an oral medication. If successful, this approach could reduce the need for knee and hip replacement surgeries.
Targeting the Root Cause of Osteoarthritis
Osteoarthritis affects nearly one in five adults in the United States and generates an estimated $65 billion annually in direct healthcare costs. Currently, no medication can slow or reverse the disease; physicians primarily rely on pain control and joint replacement procedures.
However, this new treatment directly targets the biological driver of cartilage degeneration rather than merely managing symptoms.
15-PGDH: A Master Regulator of Aging
The protein 15-PGDH functions as a master regulator of aging. Scientists classify it as a “gerozyme,” a term introduced in 2023 to describe enzymes that increase with age and drive tissue decline. Previous research showed that blocking 15-PGDH improves muscle mass and endurance in older mice, while forcing young mice to express the protein causes muscle shrinkage and weakness.
Additionally, 15-PGDH influences the regeneration of bone, nerve, and blood cells.
A Surprising Stem Cell–Independent Mechanism
In most tissues, regeneration occurs through the activation of tissue-specific stem cells. However, cartilage regeneration follows a different path.
Instead of relying on stem cells, chondrocytes alter their gene expression patterns and revert to a more youthful state. As Helen Blau explained, the researchers initially searched for stem cell involvement but found none. This discovery revealed an entirely new mechanism of adult tissue regeneration.
The study, published online in Science on November 27, was led by senior authors Helen Blau and Nidhi Bhutani.
Dramatic Cartilage Restoration in Aged Mice
The researchers observed that 15-PGDH levels in knee cartilage doubled with age in mice. They then administered a small molecule inhibitor either systemically or directly into the joint.
In both cases, the previously thinned cartilage thickened across the joint surface. Furthermore, detailed analysis confirmed that the regenerated tissue was true hyaline (articular) cartilage rather than less functional fibrocartilage.
The extent of regeneration surprised the team and demonstrated a level of cartilage repair not previously achieved with any drug intervention.
Preventing Arthritis After ACL-Type Injuries
As reported by the Stanford Medicine Press release, the team also modeled knee injuries resembling ACL tears, which frequently lead to osteoarthritis.
When researchers administered the inhibitor twice weekly for four weeks after injury, they dramatically reduced osteoarthritis development in mice. Treated animals maintained healthier cartilage, distributed weight more normally on the injured limb, and moved more naturally.
Interestingly, although prostaglandin E2 is often associated with inflammation, the study demonstrated that small increases at normal biological levels promote regeneration.
Reprogramming Cartilage Cells Toward Youthfulness
Further analysis revealed significant shifts in chondrocyte populations after treatment. Cells expressing cartilage-degrading genes declined markedly, while cells responsible for producing healthy hyaline cartilage increased substantially.
Consequently, the overall cartilage profile shifted toward a youthful, regenerative state — without activating stem cells.
Encouraging Results in Human Tissue
To confirm clinical relevance, the researchers treated human osteoarthritic cartilage removed during knee replacement surgeries. Within one week, treated tissue showed reduced cartilage-degrading genes and began regenerating articular cartilage.
This finding strengthens the possibility of translating the therapy into patient care.
Clinical Outlook and Future Directions
Phase 1 trials testing a 15-PGDH inhibitor for muscle weakness have already demonstrated safety and biological activity in healthy volunteers. Therefore, the researchers hope to launch similar trials targeting cartilage regeneration.
If successful, this therapy could transform osteoarthritis treatment by restoring native cartilage rather than replacing damaged joints. By reprogramming existing cartilage cells and blocking a central aging enzyme, scientists may have uncovered a breakthrough strategy to regenerate aging tissue and potentially eliminate the need for joint replacement surgery.